Enhanced screening via a pure DNA-encoded peptide library enabled by an Fmoc modification
Abstract
Peptide-based molecules have widespread therapeutic applications due to their potent binding affinity and relative metabolic safety. Peptide therapeutics are developed using library screening that samples a diverse chemical space within primary sequences and secondary structural conformations. DNA-encoded peptide libraries (PDELs) are ideal for the development of peptide-based therapeutics as novel building blocks, and diverse chemical modifications are easily incorporated. However, current PDEL construction is limited by precipitation-based purification, which constrains libraries to three or four building blocks in length due to decreasing quality with each synthetic step. Herein, we developed a solid-phase capture-based purification method to generate longer PDELs with increased purity. We modified the conventional Fmoc protecting group with an azido handle to introduce click chemistry for selective immobilization during purification. Using this method, we achieved >95% purity in the synthesis of a five-round PDEL that showed great efficiency in identifying high nanomolar binders against transferrin receptor protein 1. This work delivers a scalable and robust platform for generating high-quality, noncanonical peptide libraries, which marks a major breakthrough in peptide-based drug discovery.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (9)
Qiujin He
Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Yanhui Wang
School of Chemistry and Molecular Engineering
Xiyuan Tang
School of Chinese Materia Medica, Nanjing University of Chinese Medicine
Jianwei Zhang
Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Yuyu Xing
Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Zhaoyun Zong
Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Mohamed A. Elhamouly
Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Kaixian Chen
State Key Laboratory of Drug Research
Shiyu Chen